5 Key Takeaways
-
1
Sean Ianchulev, MD, MPH, will present the Kelman Innovation Lecture at ASCRS 2026, focusing on his journey from clinician to innovator.
-
2
Ianchulev will unveil new technologies in glaucoma treatment, including AlloFlo, which enhances uveoscleral outflow.
-
3
AlloSpan technology will be introduced, enabling circumferential canaloplasty with a biologic tissue implant for trabecular outflow.
-
4
The miDOC technology allows for biometric measurement of outflow during glaucoma surgery, enhancing precision in interventions.
-
5
Ianchulev emphasizes the need for integrated approaches in glaucoma care to improve outcomes for patients with moderate to severe disease.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







